関連する実験動画
Updated: Aug 11, 2026
08:45
Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 25, 2016
L-チロシンによるナルコレプシーの治療
J Mouret1, P Lemoine, P Sanchez
1Unité Clinique de Psychiatrie Biologique, Hôpital du Vinatier, Bron, France.
Lancet (London, England)
|December 24, 1988
まとめ
口服チロシンは,8人の患者のナルコレプシー症状を効果的に治療しました. 6ヶ月以内に,すべての参加者は,日中の睡眠障害とカタプレキシから解放されました.
科学分野:
- 神経学 神経学とは
- スリープ・メディシン (睡眠医学)
- 栄養に関する神経科学
背景:
- ナルコレプシーは,過度の昼間の眠気と突然の筋肉の弱さ (カタプレキシ) が特徴とする慢性神経疾患です.
- ナルコレプシーの現在の治療法は,しばしば症状を管理しますが,治療法を提供しません.
- 新種の治療薬の研究は,患者の治療結果を改善するために極めて重要です.
研究 の 目的:
- ナルコレプシーの治療における経口チロシンサプリメントの有効性を評価する.
- 昼間の睡眠発作やカタプレキシを含む主要なナルコレプシー症状に対するチロシンの影響を評価する.
主な方法:
- ナルコレプシーと診断された8人の患者からなるコホートは,研究に登録されました.
- 患者はチロシンを経口投与した.
- 治療期間を最大6ヶ月間モニターした.
主要な成果:
- 8人の患者全員が,昼間の睡眠発作の完全な寛解を経験しました.
- 8人の患者全員が,カタプレキシエピソードから解放されました.
- 症状の有意な改善は6ヶ月の治療期間内に観察されました.
結論:
- 口服チロシンは,ナルコレプシー症状の管理に重要な治療的可能性を示しています.
- ティロシンサプリメントは,ナルコレプシー患者のための新しい効果的な治療戦略を提供することができます.
- これらの発見を,より大規模で制御された試験で確認するために,さらなる研究が必要である.
さらに関連する動画
09:06Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
07:04A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats
Published on: August 19, 2018
関連する概念動画
01:24Sleep-Wake Cycles
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:07Narcolepsy
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.